Summary
The multitude of grading systems proposed for prostate adenocarcinoma illustrate the putative value of tumor grading as a predictor of prognosis. However, it also indicates the uncertainty and subjectivity of visual grading, as is confirmed by the results of several studies. Recent computer techniques enable fast image processing of microscoping images. Hence, a quantitative assessment of cellular and nuclear features can be obtained, eliminating subjectivity of visual grading. DNA-analysis and morphometric karyometry can be valuable for predicting prognosis in prostate tumors. For routine use, however, standardized preparatory techniques are mandatory. Up till now image analysis of microscopic images is a useful tool in addition to visual grading. Further standardization, inter- as well as intra-laboratory, is necessary to elaborate its value as a reproducible tool in tumor grading.
Similar content being viewed by others
References
Amberson JB, Schreiber K, Wersto R, Koizumi JH, Deitch D, Freed S, Vaughan ED, Koss LG (1987) Prognostic factors in adenocarcinoma of the prostate: A comparative, retrospective study of fine needle aspirates and corresponding tissue biopsy specimens. Acta Cytol 31:682–686
Bain GA, Koch M, Hanson J (1982) Feasibility of grading prostatic carcinoma. Arch Pathol Lab Med 106:265–267
Barzell W, Bean MA, Hilaris BS, Whitmore WF (1977) Prostatic adenocarcinoma: Relationship of grade and local extent to the pattern of metastases. J Urol 118:278–282
Bibbo M, Kim DH, di Loreto C, Dytch HE, Galera-Davidson H, Thompson D, Richards DL, Bartels HG, Bartels PH (1990a) Tissue architectural features for the grading of prostatic carcinoma. Anal Quant Cytol Histol 12:229–236
Bibbo M, Kim DH, Galera-Davidson H, di Loreto C, Dytch HE (1990b) Architectural, morphometric and photometric features and their relationship to the main subjective diagnostic clues in the grading of prostatic cancer. Anal Quant Cytol Histol 12:85–90
Bichel P, Frederiksen P, Thommesen P, Vindelov LL (1977) Flow microfluorometry and transrectal fine-needle biopsy in the classification of human prostatic carcinoma. Cancer 40:1206–1211
Blom JHM, Ten Kate FW, Schröder FH, Heul RO van der (1990) Morphometrical estimated variation in nuclear size. A useful tool in grading prostatic cancer. Urol Res 18:93–99
Böcking A (1983) Zytologische Diagnostik der Prostata. Urologe A 22:134–143
Böcking A, Sinagowitz E (1980) Histologic grading of prostatic carcinoma. Path Res Pract 168:115–125
Böcking A, Kiehn J, Heinzel-Wach M (1982) Combined histologic grading of prostatic carcinoma. Cancer 50:228–294
Böcking A, Auffermann W, Schwarz H, Bammert J, Dörrjer G, Vucicuja S (1984) Cytology of prostatic carcinoma. Quantification and validation of diagnostic criteria. Anal Quant Cytol Histol 6:74–88
Böcking A, Chatelain R, Orthen U, Gien G, von Kalckreuth G, Jocham D, Wohltmann D (1988) DNA-grading of prostatic carcinoma: prognostic validity and reproducibility. Anticancer Res 8:129–136
Brawn PN (1983) The dedifferentiation of prostate carcinoma. Cancer 52:246–251
Brawn PN, Ayala AG, Eschenbach AC von, Hussey DH, Johnson DE (1982) Histologic grading study of prostate adenocarcinoma: The development of a new system and comparison with other methods — a preliminary study. Cancer 49:525–532
Broders AC (1925) The grading of carcinoma. Minn Med 8:726–730
Busch C, Engberg A, Norlén BJ, Stenkvist B (1977) Malignancy grading of epithelial bladder tumors. Scand J Urol Nephrol 11:143–148
Byar DP, Mostofi FK (1972) Carcinoma of the prostate-prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Cancer 30:5–13
Catalona WJ, Stein AJ, Fair WR (1982) Grading errors in prostatic needle biopsies: Relation to the accuracy of tumor grade in predicting pelvic lymph node metastases. J Urol 127:919–921
Clark TD, Askin FB, Bagnell CR (1987) Nuclear roundness factor: a quantitative approach to grading in prostatic carcinoma, reliability of needle biopsy tissue, and the effect of tumor stage on usefulness. Prostate 10:199–206
Diamond DA, Berry DA, Jewett HJ, Eggleston JC, Coffey DS (1982a) A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. J Urol 128:729–732
Diamond DA, Berry DA, Umbricht SJ, Coffey DS (1982b) Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer. Prostate 3:321–326
Donohue RE, Mani JH, Whitesel JA, Mohr S, Scanavino D, Augspruger RR, Biber RJ, Fauver FE, Wettlaufer JN, Pfister RR (1982) Pelvic lymph node dissection, guide to patient management in clinically locally confined adenocarcinoma of prostate. Urology 20:559–565
Eichenberger T, Mibatsch MJ, Oberholzer M, Gschwind R, Rutishauser G (1987) Are nuclear shape factors good predictors of the disease course in patients with carcinoma of the prostate. In: Prostate cancer, pt A. Research, Endocrine Treatment, and Histopathology. Liss, New York, p 553
Epstein NA, Fatti LP (1976) Prostatic carcinoma — some morphological features affecting prognosis. Cancer 37:2455–2465
Epstein JI, Berry SJ, Eggleston JC (1984) Nuclear roundness factor: a predictor of progression in untreated stage A2 prostate cancer. Cancer 54:1666–1673
Epstein JI, Christensen WN, Steinberg GD, Carter HB (1990) Comparison of DNA ploidy and nuclear size, shape and chromatin irregularity in tissue sections and smears of prostatic carcinoma. Anal Quant Cytol Histol 12:352–358
Esch W, Latal D (1972) Das Prostatakarzinom als Zufallsbefund bei Prostatektomie. Z Urol 65:389–395
Esposti PL (1971) Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. Scand J Urol Nephrol 55:199–209
Foot NC, Humphreys GA, Coats EC (1950) Carcinoma of the prostate: A review of 162 cases with pathological classification. NY State J Med 50:84–88
Forsslund G, Zetterberg A (1990) Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma. Cancer Res 50:4281–4285
Frederiksen BP, Kjaer T, Thommesen P, Vindelov LL (1977) Flow microfluorometry and transrectal fine-needle biopsy in the classification of human prostatic carcinoma. Cancer 40:1206–1211
Gaeta JF (1981) Glandular profiles and cellular patterns in prostatic cancer grading. Urology [Suppl] 17:33–37
Gallee MPW, ten Kate FJW, Mulder PGH, Blom JHM, van der Heul RO (1990) Histological grading of prostatic carcinoma in prostatectomy specimens. Br J Urol 65:368–375
Garnett JE, Oyasu R, Grayhack JT (1984) The accuracy of diagnostic specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens. J Urol 131:690–693
Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50:125–128
Gleason DF, Mellinger GT (1974) The Veterans Administration Cooperative Urological Research group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58–63
Grayhack JT, Assimos DG (1983) Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate. Prostate 4:13–31
Harada M, Mostofi FK, Corle DK, Byar DP, Trump BF (1977) Preliminary studies of histologic prognosis in cancer of the prostate. Cancer Treat Rep 61:223–225
Hutchinson M, Schultz DS, Stephenson RA, Wong KL, Harry T, Zahniser DJ (1988) Computerized microscopic analysis of prostatic fine needle aspirates. Anal Quant Cytol Histol 11:107–110
Jones EC, McNeal J, Bruchovsky N, Jong G de (1990) DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastasis. Cancer 66:752–757
Kahler JE (1938) Carcinoma of the prostate gland. Mayo Clin Proc 13:589–592
Kastendieck H (1980) Prostatic carcinoma: aspects of pathology, prognosis and therapy. J Cancer Res Clin Oncol 96:131–156
Kate PJW ten, Gallee MPW, Schmitz PIM, Joebsis AC, Heul RO van der, Prins MEF, Blom JHM (1986) Controversy in grading of prostatic carcinoma: interobserver reproducibility of five different grading systems. World J Urol 4:147–152
Kern WH (1978) Well differentiated adenocarcinoma of the prostate. Cancer 41:2046–2054
Koss LG, Woyke S, Olszewski W (1984) The prostate. In: Aspiration biopsy: cytologic interpretation and histologic bases. Igaki-Shoin, New York, pp 223–246
Kramer SA, Spaner J, Brendler CB, Glenn JF, Paulson DF (1980) Experience with Gleason's histopathologic grading in prostatic cancer. J Urol 124:223–225
Lange PH, Narayan P (1983) Understaging and undergrading of prostate cancer. Urology 21:113–118
Layfield LJ, Mukamel E, Hilborne LH, Hannah JB, Glasgow BJ, Ljung BM, deKernion JB (1987) Cytological grading of prostatic aspiration biopsy: a comparison with the gleason grading system. J Urol 138:798–800
Lundberg S, Carstensen J, Rundquist I (1987) DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study. Cancer Res 47:1973–1977
McNeal JE (1965) Morphogenesis of prostatic carcinoma. Cancer 18:1659–1666
Mills SE, Folwer JE (1986) Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens. Cancer 57:346–349
Mohler JL, Partin AW, Epstein JI, Lohr WD, Coffey DS (1988) Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections. J Urol 139:1085–1090
Montironi R, Scarpelli M, Sisti S, Braccischi A, Gusella P, Pisani E, Alberti R, Mariuzzi GM (1990) Quantitative analysis of prostatic intraepithelial neoplasia on tissue sections. Anal Quant Cytol Histol 12:366–372
Morenas A de las, Siroky MB, Merriam J, Stilmant MM (1988) Prostatic adenocarcinoma: reproducibility and correlation with clinical stages of four grading systems. Hum Pathol 19:587–595
Mostofi FK (1975) Grading of prostatic carcinoma. Cancer Chemother Rep 59:111–117
Mostofi FK, Sobin LH, Toroni H (1973) Histological typing of prostate tumours. International Histological Classification of Tumours, no 22. WHO, Geneva
Muir EG (1934) Carcinoma of the prostate. Lancet 1:667–672
Mukamel E, deKernion JB, Dorey F, Hannah J (1990) Significance of histological prognostic indicators in patients with carcinoma of the prostate. Br J Urol 65:46–50
Murphy GP, Whitmore WF (1979) A report of the workshop on the current status of the histologic grading of prostate cancer. Cancer 44:1490–1494
Myers RP, Nevis RJ, Farcow GM, Utz DC (1982) Nucleolar grading of prostatic adenocarcinoma: light microscopic correlation with disease progression. Prostate 3:423–432
Ooms ECM, Anderson WAD, Alons CL, Boon ME, Veldhuizen RW (1983a) Analysis of the performance of pathologists in the grading of bladder tumours. Hum Pathol 14:140–143
Partin AW, Walsh AC, Pitcock RV, Mohler JL, Epstein JL, Coffey DS (1989) A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. J Urol 142:1254–1258
Paulsen DF, Stone AR, Walther PJ, Tucker JA, Cox EB (1986) Radical prostatectomy: anatomical predictors of success or failure. J Urol 136:1041–1044
Petein M, Launoit Y de, Kiss R, Deprez C, Crols K, Pasteels JL, Verhest A, Velthoven R van (1990) Characterization of the morphonuclear features and DNA ploidy of prostatic disease. Prostate 16:199–208
Peters JM, Miles BJ, Kubus JJ, Crissman JD (1990) Prognostic significance of the nuclear DNA content in localized prostatic adenocarcinoma. Anal Quant Cytol Histol 12:359–365
Pool TL, Thompson GJ (1956) Conservative treatment of carcinoma of the prostate. JAMA 160:833–837
Ray GR, Pistemma DA, Castellino RA (1976) Operative staging of apparently localized adenocarcinoma of the prostate: results in fifty unselected patients. Cancer 38:73–83
Ring KS, Karp FS, Olsson CA, O'Toole K, Bixon R, Benson MC (1990) Flow cytometric analysis of localized adenocarcinoma of the prostate: the use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropublic prostatectomy. Prostate 17:155–164
Rönström L, Tribukait B, Esposti PL (1981) DNA pattern and cytological findings in fine-needle aspirates of untreated prostatic tumors: a flow-cytofluorometric study. Prostate 2:79–88
Rous SN, Mallouh C (1972) Prostatic carcinoma: the relationship between histologic grade and incidence of early metastases. J Urol 108:905–907
Schröder FH, Belt E (1975) Carcinoma of the prostate: a study of 213 patients with stage C tumor treated by total perineal prostatectomy. J Urol 114:257–260
Schröder FH, Hop WCJ, Blom JHM, Mostofi FK (1985) Grading of prostatic cancer: III. Multivariate analysis of prognostic parameters. Prostate 7:13–20
Schultz DS, Harry T, Wong KL, Stilmant MM, Zahniser DJ, Hutchinson ML (1990) Computer-assisted grading of adenocarcinoma in prostatic aspirates. Anal Quant Cytol Histol 12:91–97
Seppelt U, Sprenger E (1984) Nuclear DNA cytophotometry in prostate carcinoma. Cytometry 5:258–262
Seppelt U, Sprenger E, Hedderich J (1986) Investigation of automated DNA diagnosis and grading of prostatic cancer. Anal Quant Cytol Histol 8:152–157
Serra J (1982) Image analysis and mathematical morphology. Academic Press, London, p 336
Sherman AB, Koss LG, Adams SE (1984) Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. Anal Quant Cytol Histol 6:112–120
Spaander PJ, Ruiter DJ, Hermans J, Voogt HJ de, Brussee JAM, Boon ME (1982) The implications of subjective recognition of malignant cells in aspirations for the grading of prostatic cancer using cell image analysis. Anal Quant Cytol 4:123–126
Sprenger E, Volk L, Michaelis WE (1974) The significance of DNA measurements in the diagnosis of prostate carcinoma. Beitr Pathol 153:370–378
Stenkvist B, Olding-Stenkvist E (1990) Cytological and DNA characteristics of hyperplasia/inflammation and cancer of the prostate. Eur J Cancer 26:261–267
Stöber U, Schmidt U (1980) Zur Klinik des Prostatakarzinoms uber Berücksichtigung zyto- und histomorphologischer Befunde. Urol Int 35:233–239
Tannenbaum M, Tannenbaum S, DeSanctis PN, Olsson CA (1982) Prognostic significance of nucleolar surface area in prostate cancer. Urology 19:546–551
Tavares AS, Costa J, Carvalho A de, Reis M (1966) Tumour ploidy in carcinomas of the bladder and prostate. Br J Cancer 20:438–441
Tribukait B, Esposti PL, Rönström L (1980) Tumor ploidy for characterization of prostatic carcinoma: flow-cytofluorometric DNA studies using aspiration biopsy material. Scand J Urol Nephrol (Suppl) 55:59–65
Tritz D, Wisecarver J, Casey J, Linder J (1989) Image analysis of fine needle aspirates (FNA) of prostatic adenocarcinoma. Lab Invest 60:97A
Utz DC, Farrow GM (1969) Pathologic differentiation and prognosis of prostatic carcinoma. JAMA 209:1701–1705
Voeth C, Droese M, Steuer G (1978) Erfahrungen mit dem zytologischen Grading beim Prostatakarzinom. Urologe A 17:367–370
Zetterberg A, Esposti PL (1976) Cytophotometric DNA analysis of aspirated cells from prostatic carcinoma. Acta Cytol 20:46–57
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Poel, H.G., Schalken, J.A. & Debruyne, F.M.J. Image analysis and grading of prostate adenocarcinoma. World J Urol 9, 86–94 (1991). https://doi.org/10.1007/BF00184039
Issue Date:
DOI: https://doi.org/10.1007/BF00184039